This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Dividend Stocks Raising Payouts

Bristol-Myers Squibb

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Bristol-Myers Squibb (BMY)

Company Profile : Bristol-Myers Squibb is a New York City-based global biopharmaceutical company, which is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceutical products on a global basis.

Bristol-Myers Squibb joined the parade of big names boosting their dividends in recent weeks, announcing a 3.1% increase to its quarterly payout.

The pharmaceutical giant, whose products include blood thinner Plavix and cancer drug Erbitux, said its board approved a dividend of 33 cents a share on its common stock, starting in the first quarter of fiscal 2011. The dividend will be payable on Feb. 1 to shareholders of record on Jan. 7.

That brings Bristol-Myers Squibb's dividend yield to around 4.98%.

Bristol-Myers said the quarterly dividend implies a total payout of $1.32 a share for fiscal 2011, although the dividend will be subject to quarterly review by the board.

Bristol-Myers had 1.7 billion shares in the third quarter of 2010, compared with 2 billion shares outstanding in the year-earlier quarter, representing a 12.3% reduction. Stock buybacks by S&P 500 companies increased 128% in the third quarter. For some S&P 500 stocks, a fourth-quarter earnings boost could be the byproduct of the buyback bonanza.

On Jan. 10 Bristol-Myers said it entered into a an agreement with Opko Health (OPK - Get Report) to collaborate on new diagnostic testing technology.

Opko's blood tests will be developed to identify biomarkers for a range of diseases including neurodegenerative disorders and other malignancies.

Under the terms of the collaborative project, Opko and Bristol-Myers will work to determine the usefulness of using Opko's technology for the diagnosis of Alzheimer's disease and other early stage cognitive impairments likely to progress to Alzeimer's.

Separately, Bristol-Myers announced it will collaborate with Pharmasset (VRUS) on the utility of combining certain inhibitors for the treatment of chronic hepatitis C virus.
4 of 11

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
COF $74.96 -0.35%
CIM $14.13 1.90%
OPK $8.80 1.10%
YHOO $31.88 3.00%
AAPL $110.72 -0.53%


Chart of I:DJI
DOW 16,912.29 +122.10 0.73%
S&P 500 1,995.83 +15.91 0.80%
NASDAQ 4,791.1520 +42.7910 0.90%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs